An Arizona vaccine company is on track to develop a new, low-cost vaccine that could save the lives of nearly every person on the planet by 2020.
The vaccine is one of several being developed by an Arizona-based company that has developed a vaccine against a strain of the influenza virus that is linked to pneumonia, liver failure and brain damage.
The new vaccine is part of an ambitious strategy to combat the pandemic that began in the United States in the summer of 2009.
The strategy is being developed to provide the vaccine to more than 20 countries and to make it affordable for the poorest.
The Arizona-made vaccine is designed to protect against the coronavirus strain, or H5N1.
The strain has killed more than 3,000 people since the start of the pandemics, including more than 300 Americans.
It is a new strain of H5, which the CDC has identified as being responsible for more than half of all new coronaviruses detected in the U.S.
This strain of virus has become increasingly deadly in recent years, and scientists say the pandemaker could spread again as it shifts from the U-shaped shape of the H5 envelope.
The AZCOV vaccine, which is designed by the company, is designed so that it will not harm healthy people who are vaccinated with AZCOVA, the company said.
The goal is to make the vaccine available in all of the countries where it is being manufactured, the Arizona Republic reported.
The company, AZCOVEX, is based in Scottsdale, Ariz., and is one step closer to getting the vaccine manufactured.
It also is working on making the vaccine more affordable, said David Gertz, AZOVEX’s CEO and co-founder.
The plan to make an affordable vaccine has been in the works for several years, Gertzz said in an interview.
The vaccines AZCOVD and AZCOVC are being developed as a joint venture by the Arizona Department of Public Health and the U of A’s Department of Biomedical Engineering.
The partnership aims to increase the supply of vaccine in developing countries.
About 20,000 AZCOVP vaccines are already in production.
AZCOVS and AZCoV vaccines are being manufactured at a company in China, AZVIG.com reported.
Gertzz is optimistic about the vaccine’s future, saying AZOVP is “the first step” toward achieving the goal of a vaccine that can save every human life.
“We believe we’re going to be the first company to have a vaccine in every country where it’s being manufactured,” Gertzman said.
“It’s not going to come cheap, but we’re hoping that this vaccine can save the world,” Gervasio said.
Follow WTOP on Twitter.